We originally explained this feature with the observation that both mutations affect the same pathway, as CEBPA is mutated in CEBPAN/C AML and is repressed by RUNX1/ETO in t(8;21) AML [24, 25]. The gene discussed is RUNX1T1; the disease is acute myeloid leukemia.